BIOTIA-ID Urine

About Biotia

Founded in 2015 and based in New York, Biotia operates at the intersection of genomics, AI, and infectious disease diagnostics. Its core offerings include the clinically validated BIOTIA-ID diagnostic assays for complex infections and urinary tract infections (UTIs), and the GeoSeeq platform, a global pandemic early warning system that integrates data from distributed labs. The company has established significant partnerships with prestigious academic and healthcare institutions and has achieved key regulatory milestones, such as securing a PLA code for its urine assay, positioning it in the commercial stage for diagnostics.

Therapeutic Areas